Computational insights into the inhibitory mechanism of human AKT1 by an orally active inhibitor, MK-2206.
The AKT signaling pathway has been identified as an important target for cancer therapy. Among small-molecule inhibitors of AKT that have shown tremendous potential in inhibiting cancer, MK-2206 is a highly potent, selective and orally active allosteric inhibitor. Promising preclinical anticancer re...
Guardado en:
Autores principales: | Mohd Rehan, Mohd A Beg, Shadma Parveen, Ghazi A Damanhouri, Galila F Zaher |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cdbecee0d83e46b68810817fb3f3c93b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- MK - Marketing más Ventas
-
Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
por: Kyle Rosenke, et al.
Publicado: (2021) -
A non-classical LysR-type transcriptional regulator PA2206 is required for an effective oxidative stress response in Pseudomonas aeruginosa.
por: F Jerry Reen, et al.
Publicado: (2013) -
MK2a inhibitor CMPD1 abrogates chikungunya virus infection by modulating actin remodeling pathway.
por: Prabhudutta Mamidi, et al.
Publicado: (2021) -
MK2a inhibitor CMPD1 abrogates chikungunya virus infection by modulating actin remodeling pathway
por: Prabhudutta Mamidi, et al.
Publicado: (2021)